Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Histamine and Immune Biomarkers in CNS Disorders.

Cacabelos R, Torrellas C, Fernández-Novoa L, López-Muñoz F.

Mediators Inflamm. 2016;2016:1924603. doi: 10.1155/2016/1924603. Epub 2016 Apr 13. Review.

2.

Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood.

Li H, Guo Z, Guo Y, Li M, Yan H, Cheng J, Wang C, Hong G.

Oncotarget. 2016 Apr 12;7(15):19089-98. doi: 10.18632/oncotarget.7862.

3.

Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response.

Cacabelos R, Torrellas C.

Int J Mol Sci. 2015 Dec 21;16(12):30483-543. doi: 10.3390/ijms161226236. Review.

4.

A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.

Carrera I, Etcheverría I, Fernández-Novoa L, Lombardi VR, Lakshmana MK, Cacabelos R, Vigo C.

Biomed Res Int. 2015;2015:807146. doi: 10.1155/2015/807146. Epub 2015 Feb 11.

5.

Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine.

Carrera I, Etcheverría I, Li Y, Fernández-Novoa L, Lombardi V, Vigo C, Palacios HH, Benberin VV, Cacabelos R, Aliev G.

Biomed Res Int. 2013;2013:709145. doi: 10.1155/2013/709145. Epub 2013 Sep 9.

6.

Total body 100-mGy X-irradiation does not induce Alzheimer's disease-like pathogenesis or memory impairment in mice.

Wang B, Tanaka K, Ji B, Ono M, Fang Y, Ninomiya Y, Maruyama K, Izumi-Nakajima N, Begum N, Higuchi M, Fujimori A, Uehara Y, Nakajima T, Suhara T, Ono T, Nenoi M.

J Radiat Res. 2014 Jan 1;55(1):84-96. doi: 10.1093/jrr/rrt096. Epub 2013 Aug 1.

7.

Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study.

Canuet L, Tellado I, Couceiro V, Fraile C, Fernandez-Novoa L, Ishii R, Takeda M, Cacabelos R.

PLoS One. 2012;7(9):e46289. doi: 10.1371/journal.pone.0046289. Epub 2012 Sep 25.

8.

Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice.

Carrera I, Etcheverría I, Fernández-Novoa L, Lombardi V, Cacabelos R, Vigo C.

Int J Alzheimers Dis. 2012;2012:376138. Epub 2012 Sep 16.

9.

Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Cacabelos R, Martínez R, Fernández-Novoa L, Carril JC, Lombardi V, Carrera I, Corzo L, Tellado I, Leszek J, McKay A, Takeda M.

Int J Alzheimers Dis. 2012;2012:518901. doi: 10.1155/2012/518901. Epub 2012 Mar 14.

10.

Using biomarkers to improve detection of Alzheimer's disease.

Biagioni MC, Galvin JE.

Neurodegener Dis Manag. 2011 Apr;1(2):127-139.

11.

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW.

Acta Neuropathol. 2011 May;121(5):571-87. doi: 10.1007/s00401-011-0826-y. Epub 2011 Apr 24. Review.

12.

Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics.

Cacabelos R.

Neuropsychiatr Dis Treat. 2007 Jun;3(3):303-33.

13.

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

McCoy MK, Tansey MG.

J Neuroinflammation. 2008 Oct 17;5:45. doi: 10.1186/1742-2094-5-45. Review.

Supplemental Content

Support Center